Arterial Stiffness in Breast Cancer Patients Treated with Anthracycline and Trastuzumab-Based Regimens

Table 2

Breast cancer characteristics.

		(%)
Tumor diameter (median)		2.5 (0.5–5)
Histological type	Invasive ductal	41 (%91)
	Micropapillary	1 (%2.2)
	Apocrine	1 (%2.2)
	Medullary	1 (%2.2)
	Inflammatory	1 (%2.2)
Lenfovascular invasion	Yes	18 (%48.9)
	No	22 (%40)
	Unknown	5 (%11.1)
Grade	Grade 1	3 (%6.7)
	Grade 2	23 (%51.1)
	Grade 3	6 (%13.3)
	Unknown	13 (%28.9)
ER	Positive	30 (%66.7)
	Negative	15 (%33.3)
PR	Positive	29 (%64.4)
	Negative	16 (%35.6)
HER 2	Positive	45 (%100)
	Negative	0

ER: estrogen receptor; PgR: progesteron receptor; HER2: human epidermal growth factor receptor.